Children Successfully MATCHed to Therapies.
Since 2017, the NCI-COG Pediatric MATCH trial has been investigating whether matching patients to targeted therapies based on genomic alterations in their tumors can be applied to kids. Interim results from the trial indicate that children and adolescents with a wide range of cancers can be successfully screened for tumor mutations and prescribed a targeted therapy.